Compare DMCC Speciality with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate 15.49% of over the last 5 years
With a growth in Net Profit of 162.89%, the company declared Very Positive results in Jun 26
With ROCE of 14.4, it has a Fair valuation with a 2.5 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.02% of the company
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 718 Cr (Micro Cap)
18.00
43
0.85%
0.33
11.01%
2.95
Total Returns (Price + Dividend) 
Latest dividend: 2.5 per share ex-dividend date: Aug-22-2025
Risk Adjusted Returns v/s 
Returns Beta
News

DMCC Speciality Chemicals Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals
DMCC Speciality Chemicals Ltd has seen its investment rating downgraded from Buy to Hold following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite strong quarterly financial performance, evolving market dynamics and mixed technical signals have prompted a more cautious stance on this micro-cap specialty chemicals player.
Read full news article
DMCC Speciality Chemicals Ltd Sees Technical Momentum Shift Amid Mixed Market Returns
DMCC Speciality Chemicals Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price momentum and technical indicators suggest a cautiously optimistic outlook amid volatility in the specialty chemicals sector.
Read full news article
DMCC Speciality Chemicals Ltd is Rated Buy
DMCC Speciality Chemicals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news article Announcements 
Submission Of Notice Of The 105Th Annual General Meeting (AGM) For The Financial Year 2025-26.
18-Aug-2026 | Source : BSEAs per attachment.
Reg. 34 (1) Annual Report.
18-Aug-2026 | Source : BSESubmission of Annual Report and Notice of the 105th Annual General Meeting (AGM) for the Financial Year 2025-26.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13-Aug-2026 | Source : BSEPress Release on financial performance for Q1 FY27
Corporate Actions 
No Upcoming Board Meetings
DMCC Speciality Chemicals Ltd has declared 25% dividend, ex-date: 21 Aug 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 2 FIIs (0.15%)
Laxmikumar Narottam Goculdas (36.27%)
Girish Gulati (huf) . (2.28%)
32.85%
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 99.16% vs 48.90% in Jun 2025
YoY Growth in quarter ended Jun 2026 is 162.89% vs 466.42% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024
Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 31.97% vs 26.15% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 30.76% vs 158.59% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 34.84% vs 31.51% in Mar 2025
YoY Growth in year ended Mar 2026 is 26.94% vs 85.76% in Mar 2025






